Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Amer H. Zureikat"'
Autor:
Alessandro Paniccia, Nathan Bahary, David L Bartlett, Kenneth K. Lee, Kenneth J. Smith, Amer H. Zureikat, Caroline J. Rieser, Sowmya Narayanan
Publikováno v:
J Surg Oncol
INTRODUCTION: Neoadjuvant therapy (NAT) is an emerging strategy for operable pancreatic ductal adenocarcinoma (PDAC). While neoadjuvant therapy increases multimodal therapy completion, it risks functional decline and treatment drop out. We used decis
Autor:
Brian A. Boone, Kelsey A. Musgrove, Carl Schmidt, Alan A Thomay, Pavan Rao, Britney R. Harris, Melissa E. Hogg, Herbert J. Zeh, Amer H. Zureikat, J. Wallis Marsh
Publikováno v:
J Surg Oncol
Introduction The learning curve associated with robotic pancreatoduodenectomy (RPD) is a hurdle for new programs to achieve optimal results. Since early analysis, robotic training has recently expanded, and the RPD approach has been refined. The purp
Autor:
Alessandro Paniccia, Ibrahim Nassour, Samer AlMasri, Samer Tohme, Amer H. Zureikat, Kenneth K. Lee, David L. Bartlett, Richard S. Hoehn, Mohamed A. Adam
Publikováno v:
Journal of Surgical Oncology. 122:707-715
Background Open extended cholecystectomy (O-EC) has long been the recommended treatment for resectable gallbladder cancer (GBC), while the minimally-invasive approach for EC (MIS-EC) remains controversial. Our aim was to analyze overall survival of G
Autor:
Caroline J. Rieser, David L. Bartlett, Asmita Chopra, Kenneth K.W. Lee, Sowmya Narayanan, Amer H. Zureikat, Alessandro Paniccia, Samer AlMasri, Tracy Daum, Mazen S. Zenati, Katelyn Smith, Nathan Bahary, Vivianne Oyefusi, Ibrahim Nassour
Publikováno v:
J Surg Oncol
BACKGROUND AND OBJECTIVES Neoadjuvant chemotherapy (NAT) for pancreatic adenocarcinoma (PDAC) is increasingly being utilized. However, a significant number of patients will experience early recurrence, possibly negating the benefit of surgery. We aim
Autor:
Jennifer Steve, Heather L. Jones, Mazen S. Zenati, Samantha Perkins, James F. Pingpank, Melissa E. Hogg, Haroon A. Choudry, Herbert J. Zeh, David L. Bartlett, Mashaal Dhir, Amber K. Clifford, Matthew P. Holtzman, Amer H. Zureikat, James C. Padussis
Publikováno v:
Journal of Surgical Oncology. 114:342-347
Background Hepatic artery infusion (HAI) chemotherapy can be combined with systemic chemotherapy for the treatment of isolated unresectable colorectal liver metastases (IU-CRLM) and intrahepatic cholangiocarcinoma (U-ICC). However, HAI pump placement
Autor:
Aatur D. Singhi, Mazen S. Zenati, Shirin Sabbaghian, Alyssa M. Krasinskas, J. Wallis Marsh, Herbert J. Zeh, A. James Moser, Amer H. Zureikat, Brian A. Boone
Publikováno v:
Journal of Surgical Oncology. 110:171-175
Background and Objectives Venous resection of locally advanced pancreatic cancer is associated with increased morbidity and mortality; therefore identification of patients most likely to benefit from this aggressive surgical approach is an important
Autor:
Barry C. Lembersky, Jennifer Steve, Ronald G. Stoller, Nathan Bahary, Brian A. Boone, Alyssa M. Krasinskas, Michael K. Gibson, Amer H. Zureikat, Herbert J. Zeh
Publikováno v:
Journal of Surgical Oncology. 108:236-241
Background Trials examining FOLFIRINOX in metastatic pancreatic cancer demonstrate higher response rates compared to gemcitabine-based regimens. There is currently limited experience with neoadjuvant FOLFIRINOX in pancreatic cancer.
Autor:
Joel M. Baumgartner, Herbert J. Zeh, Amer H. Zureikat, Matthew P. Holtzman, Heather L. Jones, Lekshmi Ramalingam, Steven A. Ahrendt, James F. Pingpank, Haroon A. Choudry, David L. Bartlett
Publikováno v:
Journal of Surgical Oncology. 107:329-334
Background: and Objectives Peritoneal sarcomatosis responds poorly to systemic chemotherapy and demonstrates high rates of recurrence after resection. We sought to determine perioperative and oncologic outcomes after cytoreductive surgery (CRS) and h
Autor:
Mashaal, Dhir, Mazen S, Zenati, James C, Padussis, Heather L, Jones, Samantha, Perkins, Amber K, Clifford, Jennifer, Steve, Melissa E, Hogg, Haroon A, Choudry, Matthew P, Holtzman, Herbert J, Zeh, James F, Pingpank, David L, Bartlett, Amer H, Zureikat
Publikováno v:
Journal of surgical oncology. 114(3)
Hepatic artery infusion (HAI) chemotherapy can be combined with systemic chemotherapy for the treatment of isolated unresectable colorectal liver metastases (IU-CRLM) and intrahepatic cholangiocarcinoma (U-ICC). However, HAI pump placement requires a
Autor:
Brian A, Boone, Shirin, Sabbaghian, Mazen, Zenati, J Wallis, Marsh, A James, Moser, Amer H, Zureikat, Aatur D, Singhi, Herbert J, Zeh, Alyssa M, Krasinskas
Publikováno v:
Journal of surgical oncology. 110(2)
Venous resection of locally advanced pancreatic cancer is associated with increased morbidity and mortality; therefore identification of patients most likely to benefit from this aggressive surgical approach is an important goal. Loss of SMAD4 staini